Follow these steps if you’re facing HA injection non-coverage
Orthopedic practices need to keep close tabs on their payer policies for hyaluronic acid (HA) treatment to ensure they have the earliest possible word on any payment changes, a reimbursement expert warns.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.